Novasep

Synthesis and purification for the life sciences
January 2007
www.novasep.com

Business
Groupe Novasep operates through two complementary divisions. Novasep Synthesis offers custom synthesis services utilizing niche technologies to produce elaborate molecules for the pharmaceutical industry, as well as producing and marketing proprietary products, typically generics. Novasep Process provides turn-key physical purification solutions to industrial biotech, pharmaceutical and the growing bio-pharma industries. Headquartered in Pompey (France), Novasep operates mainly in Europe, with subsidiaries in the United States, China and Japan and 1300 employees working in nine sites.

Development
Gilde completed the acquisition of Novasep from Rockwood Specialties in January 2007. Novasep is ideally positioned to benefit from the strong growth of the pharma and biotech sectors. Future development of Novasep aims at increasing its penetration of generic drug manufacturing and biotechnology segments as well as broadening its technological portfolio through targeted acquisitions.